Goodwin Procter advised SpringWorks Therapeutics on the deal. SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ducentis BioTherapeutics on the deal. Ducentis BioTherapeutics announced its acquisition by Arcutis Biotherapeutics for up to $400 million. Ducentis BioTherapeutics, a portfolio company of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TIME on the deal. TIME announced its acquisition of Brandcast, the leading no-code platform for creating and managing enterprise-grade websites. Through the acquisition, Brandcast’s...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
You must be a Standard 1 Year member to access this content.
Goodwin a conseillé Azulis Capital dans le cadre de la cession de Novepan. Le Management de Novepan était conseillé par Piotraut Giné Avocats. Sagard était conseillé...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Shopify on the matter while Goodwin represented Klaviyo. On August 2, 2022, Shopify announced it has made a $100 million...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Lacerta Therapeutics on the deal. Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised iRobot Corporation on the deal, while Paul, Weiss advised Amazon. iRobot Corporation (NASDAQ: IRBT) announced its definitive agreement to be acquired by Amazon.com, Inc....
You must be a Standard 1 Year member to access this content.
Goodwin advised Intermediate Capital Group on the deal. Intermediate Capital Group announced the structuring and fundraising of its eighth European Corporate fund. The Fund held a final...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Medipost Co. on the deal. Medipost Co. announced its strategic agreement with OmniaBio, Inc., a subsidiary of the Centre for Commercialization of Regenerative Medicine...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Polychain Capital on the deal. Polychain Capital announced its lead investment in Vespene Energy’s $4.3 million financing round. Polychain Capital is a premier investor...
You must be a Standard 1 Year member to access this content.
